Do firms respond to peer disclosures? Evidence from disclosures of clinical trial results
Using data on the registration of clinical trials and the disclosure of trial results, we examine how firms respond to peer disclosures. We find that firms are less likely to disclose their own trial results if the results of a larger number of closely related trials are disclosed by their peers. Th...
Saved in:
Main Authors: | , , , |
---|---|
Format: | text |
Language: | English |
Published: |
Institutional Knowledge at Singapore Management University
2023
|
Subjects: | |
Online Access: | https://ink.library.smu.edu.sg/soa_research/1979 https://ink.library.smu.edu.sg/context/soa_research/article/3006/viewcontent/SSRN_id3344942otto.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Singapore Management University |
Language: | English |
id |
sg-smu-ink.soa_research-3006 |
---|---|
record_format |
dspace |
spelling |
sg-smu-ink.soa_research-30062023-09-06T06:36:38Z Do firms respond to peer disclosures? Evidence from disclosures of clinical trial results CAPKUN, Vedran LOU, Yun OTTO, Clemens A. WANG, Yin Using data on the registration of clinical trials and the disclosure of trial results, we examine how firms respond to peer disclosures. We find that firms are less likely to disclose their own trial results if the results of a larger number of closely related trials are disclosed by their peers. This relation is stronger if the firms face higher competition (as measured by the number of competing trials). It is weaker if the firms are further along in their research than the peers (as measured by the trials’ phase) and if the peers’ disclosures convey more negative news (as measured by the firms’ stock price reaction). We also find that firms are more likely to abandon ongoing trials if a larger number of peers disclose the results of closely related trials. Additional tests suggest that this real effects channel does not drive the impact on the firms’ disclosure decisions. 2023-05-01T07:00:00Z text application/pdf https://ink.library.smu.edu.sg/soa_research/1979 info:doi/10.2308/tar-2019-0137 https://ink.library.smu.edu.sg/context/soa_research/article/3006/viewcontent/SSRN_id3344942otto.pdf http://creativecommons.org/licenses/by-nc-nd/4.0/ Research Collection School Of Accountancy eng Institutional Knowledge at Singapore Management University disclosure decisions peer disclosures clinical trials Accounting Clinical Trials |
institution |
Singapore Management University |
building |
SMU Libraries |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
SMU Libraries |
collection |
InK@SMU |
language |
English |
topic |
disclosure decisions peer disclosures clinical trials Accounting Clinical Trials |
spellingShingle |
disclosure decisions peer disclosures clinical trials Accounting Clinical Trials CAPKUN, Vedran LOU, Yun OTTO, Clemens A. WANG, Yin Do firms respond to peer disclosures? Evidence from disclosures of clinical trial results |
description |
Using data on the registration of clinical trials and the disclosure of trial results, we examine how firms respond to peer disclosures. We find that firms are less likely to disclose their own trial results if the results of a larger number of closely related trials are disclosed by their peers. This relation is stronger if the firms face higher competition (as measured by the number of competing trials). It is weaker if the firms are further along in their research than the peers (as measured by the trials’ phase) and if the peers’ disclosures convey more negative news (as measured by the firms’ stock price reaction). We also find that firms are more likely to abandon ongoing trials if a larger number of peers disclose the results of closely related trials. Additional tests suggest that this real effects channel does not drive the impact on the firms’ disclosure decisions. |
format |
text |
author |
CAPKUN, Vedran LOU, Yun OTTO, Clemens A. WANG, Yin |
author_facet |
CAPKUN, Vedran LOU, Yun OTTO, Clemens A. WANG, Yin |
author_sort |
CAPKUN, Vedran |
title |
Do firms respond to peer disclosures? Evidence from disclosures of clinical trial results |
title_short |
Do firms respond to peer disclosures? Evidence from disclosures of clinical trial results |
title_full |
Do firms respond to peer disclosures? Evidence from disclosures of clinical trial results |
title_fullStr |
Do firms respond to peer disclosures? Evidence from disclosures of clinical trial results |
title_full_unstemmed |
Do firms respond to peer disclosures? Evidence from disclosures of clinical trial results |
title_sort |
do firms respond to peer disclosures? evidence from disclosures of clinical trial results |
publisher |
Institutional Knowledge at Singapore Management University |
publishDate |
2023 |
url |
https://ink.library.smu.edu.sg/soa_research/1979 https://ink.library.smu.edu.sg/context/soa_research/article/3006/viewcontent/SSRN_id3344942otto.pdf |
_version_ |
1779157096488501248 |